Katherine Hadlandsmyth1,2, Hilary Mosher1,3, Mark W Vander Weg1,3, Brian C Lund4. 1. Center for Comprehensive Access and Delivery Research and Evaluation (CADRE), Iowa City VA Healthcare System, Iowa City, IA, USA. 2. Department of Anesthesia, Carver College of Medicine, University of Iowa, Iowa City, IA, USA. 3. Department of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA, USA. 4. Center for Comprehensive Access and Delivery Research and Evaluation (CADRE), Iowa City VA Healthcare System, Iowa City, IA, USA. brian.lund@va.gov.
Abstract
BACKGROUND: Improved understanding of temporal trends in short- and long-term opioid prescribing may inform efforts to curb the opioid epidemic. OBJECTIVE: To characterize the prevalence of short- and long-term opioid prescribing in the Veterans Health Administration (VHA) from 2010 to 2016. DESIGN: Observational cohort study using VHA databases. PARTICIPANTS: All patients receiving at least one outpatient prescription through the VHA during calendar years 2010 through 2016. MAIN MEASURES: Prevalence of opioid use from 2010 through 2016, stratified by short-term, intermediate-term, and long-term use. Temporal trends in discontinuation among existing long-term users and initiation of new long-term use and the net impact on rates of long-term opioid use. Relative likelihood of transitioning to long-term opioid use contrasted with use patterns in the prior year. KEY RESULTS: The prevalence of opioid prescribing was 20.8% in 2010, peaked at 21.2% in 2012, and declined annually to 16.1% in 2016. Between 2010 and 2016, reductions in long-term opioid prescribing accounted for 83% of the overall decline in opioid prescription fills. Comparing data from 2010-2011 to data from 2015-2016, declining rates in new long-term use accounted for more than 90% of the decreasing prevalence of long-term opioid use in the VHA, whereas increases in cessation among existing long-term users accounted for less than 10%. The relative risk of transitioning to long-term use during 2016 was 6.5 (95% CI: 6.4, 6.7) among short-term users and 35.5 (95% CI: 34.8, 36.3) among intermediate users, relative to patients with no opioid prescriptions filled during 2015. CONCLUSIONS: Opioid prescribing trends followed similar trajectories in VHA and non-VHA settings, peaking around 2012 and subsequently declining. However, changes in long-term opioid prescribing accounted for most of the decline in the VHA. Recent VA opioid initiatives may be preventing patients from initiating long-term use. This may offer valuable lessons generalizable to other healthcare systems.
BACKGROUND: Improved understanding of temporal trends in short- and long-term opioid prescribing may inform efforts to curb the opioid epidemic. OBJECTIVE: To characterize the prevalence of short- and long-term opioid prescribing in the Veterans Health Administration (VHA) from 2010 to 2016. DESIGN: Observational cohort study using VHA databases. PARTICIPANTS: All patients receiving at least one outpatient prescription through the VHA during calendar years 2010 through 2016. MAIN MEASURES: Prevalence of opioid use from 2010 through 2016, stratified by short-term, intermediate-term, and long-term use. Temporal trends in discontinuation among existing long-term users and initiation of new long-term use and the net impact on rates of long-term opioid use. Relative likelihood of transitioning to long-term opioid use contrasted with use patterns in the prior year. KEY RESULTS: The prevalence of opioid prescribing was 20.8% in 2010, peaked at 21.2% in 2012, and declined annually to 16.1% in 2016. Between 2010 and 2016, reductions in long-term opioid prescribing accounted for 83% of the overall decline in opioid prescription fills. Comparing data from 2010-2011 to data from 2015-2016, declining rates in new long-term use accounted for more than 90% of the decreasing prevalence of long-term opioid use in the VHA, whereas increases in cessation among existing long-term users accounted for less than 10%. The relative risk of transitioning to long-term use during 2016 was 6.5 (95% CI: 6.4, 6.7) among short-term users and 35.5 (95% CI: 34.8, 36.3) among intermediate users, relative to patients with no opioid prescriptions filled during 2015. CONCLUSIONS: Opioid prescribing trends followed similar trajectories in VHA and non-VHA settings, peaking around 2012 and subsequently declining. However, changes in long-term opioid prescribing accounted for most of the decline in the VHA. Recent VA opioid initiatives may be preventing patients from initiating long-term use. This may offer valuable lessons generalizable to other healthcare systems.
Authors: Konstantinos S Mylonas; Michael Reinhorn; Lauren R Ott; Maggie L Westfal; Peter T Masiakos Journal: Surgery Date: 2017-08-01 Impact factor: 3.982
Authors: Chad M Brummett; Jennifer F Waljee; Jenna Goesling; Stephanie Moser; Paul Lin; Michael J Englesbe; Amy S B Bohnert; Sachin Kheterpal; Brahmajee K Nallamothu Journal: JAMA Surg Date: 2017-06-21 Impact factor: 14.766
Authors: Erik R Vanderlip; Mark D Sullivan; Mark J Edlund; Bradley C Martin; John Fortney; Mark Austen; James S Williams; Teresa Hudson Journal: Pain Date: 2014-09-30 Impact factor: 6.961
Authors: Roger Chou; Debra B Gordon; Oscar A de Leon-Casasola; Jack M Rosenberg; Stephen Bickler; Tim Brennan; Todd Carter; Carla L Cassidy; Eva Hall Chittenden; Ernest Degenhardt; Scott Griffith; Renee Manworren; Bill McCarberg; Robert Montgomery; Jamie Murphy; Melissa F Perkal; Santhanam Suresh; Kathleen Sluka; Scott Strassels; Richard Thirlby; Eugene Viscusi; Gary A Walco; Lisa Warner; Steven J Weisman; Christopher L Wu Journal: J Pain Date: 2016-02 Impact factor: 5.820
Authors: Katherine Hadlandsmyth; Hilary J Mosher; Emine O Bayman; Justin G Wikle; Brian C Lund Journal: J Gen Intern Med Date: 2020-03-23 Impact factor: 5.128
Authors: Jessica J Wyse; Adam J Gordon; Steven K Dobscha; Benjamin J Morasco; Elizabeth Tiffany; Karen Drexler; Friedhelm Sandbrink; Travis I Lovejoy Journal: Subst Abus Date: 2018 Impact factor: 3.716
Authors: Jeffrey F Scherrer; Joanne Salas; Patrick Lustman; Peter Tuerk; Sarah Gebauer; Sonya B Norman; F David Schneider; Kathleen M Chard; Carissa van den Berk-Clark; Beth E Cohen; Paula P Schnurr Journal: Eur J Prev Cardiol Date: 2019-05-13 Impact factor: 7.804
Authors: Friedhelm Sandbrink; Elizabeth M Oliva; Tara L McMullen; Amy R Aylor; Michael A Harvey; Melissa L Christopher; Francesca Cunningham; Taeko Minegishi; Thomas Emmendorfer; Jenie M Perry Journal: J Gen Intern Med Date: 2020-11-16 Impact factor: 5.128
Authors: Shari S Rogal; Lauren A Beste; Ada Youk; Michael J Fine; Bryan Ketterer; Hongwei Zhang; Steven Leipertz; Maggie Chartier; Chester B Good; Kevin L Kraemer; Matthew Chinman; Timothy Morgan; Walid F Gellad Journal: Clin Gastroenterol Hepatol Date: 2018-10-17 Impact factor: 11.382
Authors: Taeko Minegishi; Melissa M Garrido; Michael Stein; Elizabeth M Oliva; Austin B Frakt Journal: J Gen Intern Med Date: 2020-11-03 Impact factor: 5.128
Authors: Pooja Lagisetty; Claire Garpestad; Angela Larkin; Colin Macleod; Derek Antoku; Stephanie Slat; Jennifer Thomas; Victoria Powell; Amy S B Bohnert; Lewei A Lin Journal: Drug Alcohol Depend Date: 2021-02-13 Impact factor: 4.492